EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High incidence of antibiotic resistance amongst isolates of Helicobacter pylori collected in Nottingham, UK, between 2001 and 2018

Elizabeth Garvey, Joanne Rhead, Suffi Suffian, Daniel Whiley, Farah Mahmood, Naveen Bakshi, Darren Letley, Jonathan White, John Atherton, Jody Anne Winter, Karen Robinson

Journal of Medical Microbiology · 2023

DOI: 10.1099/jmm.0.001776 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Microbiology, 2023. Verfasst von Elizabeth Garvey und 10 weiteren Autor:innen. Beteiligte Einrichtung: Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham, UK. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, NIHR Nottingham Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Helicobacter pylori is the leading cause of peptic ulcers and gastric cancer. The most common treatment regimens use combinations of two or three antibiotics and a proton pump inhibitor (PPI) to suppress stomach acid. The World Health Organization designated clarithromycin-resistant H. pylori as a high priority pathogen for drug development, due to increasing antibiotic resistance globally. Hypothesis/Gap Statement. There is no routine surveillance of H. pylori primary antimicrobial sensitivities in the UK, and published data are lacking.

Aim

This study aimed to characterize antimicrobial sensitivities of isolates collected in Nottingham, UK, between 2001 and 2018. Methodology. Gastric biopsy samples were collected, with informed written consent and ethics approval, from 162 patients attending the Queen’s Medical Centre in Nottingham for an upper GI tract endoscopy. Antibiotic sensitivity was assessed using E-Tests and a more cost-effective disc diffusion test.

Results

The clarithromycin, amoxicillin and levofloxacin disc diffusion tests provided identical results to E-Tests on a subset of 30 isolates. Disparities were observed in the metronidazole test results, however. In total, 241 isolates from 162 patients were tested using at least one method. Of all isolates, 28 % were resistant to clarithromycin, 62 % to metronidazole and 3 % to amoxicillin, which are used in first-line therapies. For those antibiotics used in second- and third-line therapies, 4 % were resistant to levofloxacin and none of the isolates were resistant to tetracycline. Resistance to more than one antibiotic was found in 27 % of isolates. The frequency of patients with a clarithromycin-resistant strain increased dramatically over time: from 16 % between 2001 and 2005 to 40 % between 2011 and 2018 ( P =0.011). For the same time periods, there was also an increase in those with a metronidazole-resistant strain (from 58 to 78 %; P =0.05). The frequencies of clarithromycin and metronidazole resistance were higher in isolates from patients who had previously received eradication therapy, compared to those who had not (40 % versus 77 %, and 80 % versus 92 %, respectively). Of 79 pairs of isolates from the antrum and corpus regions of the same patient’s stomach, only six had differences in their antimicrobial susceptibility profiles.

Conclusion

Although there was high and increasing resistance to clarithromycin and metronidazole, there was no resistance to tetracycline and the frequencies of amoxicillin and levofloxacin resistance were very low.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter pyloriHelicobacter InfectionsHumansClarithromycinMetronidazoleLevofloxacinIncidenceMicrobial Sensitivity TestsAnti-Bacterial AgentsAmoxicillinTetracyclineDrug Resistance, MicrobialUnited Kingdom

Stichwörter der Autor:innen

Helicobacter pyloriamoxicillinantimicrobial resistanceclarithromycinlevofloxacinmetronidazolesusceptibility testing

Substanzen

ClarithromycinMetronidazoleLevofloxacinAnti-Bacterial AgentsAmoxicillinTetracycline

Autor:innen und Institutionen

  • Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham, UK.
  • NIHR Nottingham BRC, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.
  • Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.
  • School of Science and Technology, Nottingham Trent University, Nottingham, UK.
  • School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.
  • Present address: Salisbury District Hospital, Salisbury, UK.

Förderung

  • Wellcome Trust
  • Medical Research Council
  • NIHR Nottingham Biomedical Research Centre

Zitieren

APA

Garvey, E., Rhead, J., Suffian, S., Whiley, D., Mahmood, F., Bakshi, N., Letley, D., White, J., Atherton, J., Winter, J. A., & Robinson, K. (2023). High incidence of antibiotic resistance amongst isolates of Helicobacter pylori collected in Nottingham, UK, between 2001 and 2018. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.001776

Vancouver

Garvey E, Rhead J, Suffian S, Whiley D, Mahmood F, Bakshi N, et al. High incidence of antibiotic resistance amongst isolates of Helicobacter pylori collected in Nottingham, UK, between 2001 and 2018. Journal of Medical Microbiology. 2023. doi:10.1099/jmm.0.001776

BibTeX
@article{Garvey2023,
  author = {Garvey, Elizabeth and Rhead, Joanne and Suffian, Suffi and Whiley, Daniel and Mahmood, Farah and Bakshi, Naveen and Letley, Darren and White, Jonathan and Atherton, John and Winter, Jody Anne and Robinson, Karen},
  title = {High incidence of antibiotic resistance amongst isolates of Helicobacter pylori collected in Nottingham, UK, between 2001 and 2018},
  journal = {Journal of Medical Microbiology},
  year = {2023},
  doi = {10.1099/jmm.0.001776}
}
Kostenlos starten →